3
Announcements
Trials
Browse
Landscape
Phase
Phase 3
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Conditions
Whooping Cough
1
Uterine Cervical Neoplasms
1
Uterine Cervical Dysplasia
1
Solid Tumor
1
Pneumococcal Infections
1
Neoplasm Metastasis
1
Measles
1
Hepatitis B
1
HIV Infections
1
Condylomata Acuminata
1
Interventions
Human Papillomavirus Recombinant Vaccine Quadrivalent, Types 6, 11, 16, 18
11
Vaccines, Synthetic
7
Papillomavirus Vaccines
6
Vaccines
3
Imiquimod
3
Gels
3
green tea extract polyphenone E
2
Trichloroacetic Acid
2
Duration of Therapy
2
Cantharidin
2
ranpirnase
1
polyphenon E
1
nanocurcumin
1
human papillomavirus vaccine, L1 type 16, 18
1
berdazimer sodium
1
Viusid
1
VP-102
1
Therapies, Investigational
1
Tea
1
Surgical Procedures, Operative
1
Omiganan
1
Ointments
1
Medical Records
1
Interleukin-4
1
Human Papillomavirus Recombinant Vaccine nonavalent
1
Hepatitis B Vaccines
1
GS-9191
1
Ethanol
1
Cyclophosphamide
1
Curcumin
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Completed
×
Condylomata Acuminata
×
Hepatitis B Vaccines
×
Clear all
NCT02750202
2026-01-23
TheraVACCS
University of Pretoria
Phase 3
Completed
52 enrolled
34 charts